United Kingdom · Question · Written question
UIN 33692
Ruxolitinib
Introduced
25 February 2025
Last action
3 March 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
3 March 2025
Summary
To ask the Secretary of State for Health and Social Care, whether he plans to (a) utilise the complex patient access scheme to make Ruxolitinib available on the NHS and (b) consider other options for vitiligo patients to receive that medication.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
25 February 2025
Written question
To ask the Secretary of State for Health and Social Care, whether he plans to (a) utilise the complex patient access scheme to make Ruxolitinib available on the NHS and (b) consider other options for vitiligo patients to receive that medication.
Source: Commons
3 March 2025
Answer
It is for the marketing authorisation holder to propose a complex patient access scheme for a medicine being evaluated by the National Institute for Health and Care Excellence (NICE), which would then be considered by the NICE and NHS England through the ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-02-25/33692
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1778425
- uk · wq-1778425 · source updated 3 March 2025